Stonepine Capital Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,540,671
| Closed | -$2.84M | – | 23 |
|
|
2022
Q3 | $2.84M | Sell |
1,540,671
-1,947,257
| -56% | -$3.58M | 1.27% | 15 |
|
|
2022
Q2 | $7.5M | Sell |
3,487,928
-730,141
| -17% | -$1.57M | 3.49% | 13 |
|
|
2022
Q1 | $13.2M | Buy |
4,218,069
+211,884
| +5% | +$665K | 5.49% | 5 |
|
|
2021
Q4 | $12.9M | Buy |
4,006,185
+753,293
| +23% | +$2.42M | 5.9% | 5 |
|
|
2021
Q3 | $10.9M | Buy |
3,252,892
+1,252,892
| +63% | +$4.21M | 4.97% | 5 |
|
|
2021
Q2 | $7.82M | Sell |
2,000,000
-483,059
| -19% | -$1.89M | 4.09% | 7 |
|
|
2021
Q1 | $9.98M | Buy |
+2,483,059
| New | +$9.98M | 5.39% | 6 |
|